Wedbush Starts Francesca's Holdings (FRAN) at Outperform
Get Alerts FRAN Hot Sheet
Price: $2.22 --0%
Rating Summary:
9 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
9 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Wedbush initiated coverage on Francesca's Holdings (NASDAQ: FRAN) with an Outperform rating and price target of $25.00.
Analyst Morry Brown said, "Look for 1Q to provide SSS inflection; we expect first sequential comp improvement in 7 quarters. Following a challenging 2013, we look for FRAN to return to positive SSS in 1Q14 based on (1) broader fashion trends shifting towards the company’s feminine and bohemian aesthetic, (2) lapping the easiest comparisons FRAN has cycled as a public company and (3) a generally improved consumer spending environment as last year’s payroll tax increase is lapped."
For an analyst ratings summary and ratings history on Francesca's Holdings click here. For more ratings news on Francesca's Holdings click here.
Shares of Francesca's Holdings closed at $18.96 yesterday.
Analyst Morry Brown said, "Look for 1Q to provide SSS inflection; we expect first sequential comp improvement in 7 quarters. Following a challenging 2013, we look for FRAN to return to positive SSS in 1Q14 based on (1) broader fashion trends shifting towards the company’s feminine and bohemian aesthetic, (2) lapping the easiest comparisons FRAN has cycled as a public company and (3) a generally improved consumer spending environment as last year’s payroll tax increase is lapped."
For an analyst ratings summary and ratings history on Francesca's Holdings click here. For more ratings news on Francesca's Holdings click here.
Shares of Francesca's Holdings closed at $18.96 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amazon.com (AMZN) PT Raised to $215 at UBS
- META to capture largest share of users, SNAP to benefit from ad budget shifts - Canaccord Genuity weighs in on TikTok ban
- Sage Therapeutics (SAGE) PT Lowered to $18 at Truist Securities
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, New Coverage, Retail SalesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!